These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5941740)

  • 1. Variations of urinary creatinine and its correlation to excretion of indole metabolites in mental patients.
    Pscheidt GR; Berlet HH; Spaide J; Himwich HE
    Clin Chim Acta; 1966 Feb; 13(2):228-34. PubMed ID: 5941740
    [No Abstract]   [Full Text] [Related]  

  • 2. Indoleamine metabolism in affective disorders: excretion of tryptamine, indoleacetic acid and 5-hydroxy-indoleacetic acid in depressive states.
    McNamee HB; Moody JP; Naylor GJ
    J Psychosom Res; 1972 Feb; 16(1):63-70. PubMed ID: 5058989
    [No Abstract]   [Full Text] [Related]  

  • 3. ENDOGENOUS METABOLIC FACTOR IN SCHIZOPHRENIC BEHAVIOR.
    BERLET HH; BULL C; HIMWICH HE; KOHL H; MATSUMOTO K; PSCHEIDT GR; SPAIDE J; TOURLENTES TT; VALVERDE JM
    Science; 1964 Apr; 144(3616):311-3. PubMed ID: 14169724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of amines in placental function. Monoamine metabolism in pregnancy.
    Sandler M
    Proc R Soc Med; 1966 Aug; 59(8):741-4. PubMed ID: 5911435
    [No Abstract]   [Full Text] [Related]  

  • 5. Study of excretion of 5-hydroxyindoleacetic acid in mental patients.
    VALCOURT AJ
    AMA Arch Neurol Psychiatry; 1959 Mar; 81(3):292-8. PubMed ID: 13626280
    [No Abstract]   [Full Text] [Related]  

  • 6. [Transformation of tryptamine by Aspergillus niger].
    Dvornikova TP; Skriabin GK; Suvorov NN
    Mikrobiologiia; 1968; 37(2):228-32. PubMed ID: 5732065
    [No Abstract]   [Full Text] [Related]  

  • 7. The excretion of 5-hydroxyindoleacetic acid in the heterozygous carrier for phenylketonuria.
    HSIA DY; ROWLEY WA; HUANG I
    J Ment Defic Res; 1961 Jun; 5():4-9. PubMed ID: 13716364
    [No Abstract]   [Full Text] [Related]  

  • 8. Tryptophan loading and excretion of 5-hydroxyindoleacetic acid in normal and schizophrenic subjects.
    KOPIN IJ
    Science; 1959 Mar; 129(3352):835-6. PubMed ID: 13635020
    [No Abstract]   [Full Text] [Related]  

  • 9. EXCRETION OF DOPAMINE, CATECHOLAMINE METABOLITES AND 5-HYDROXYINDOLEACETIC ACID IN HEPATOLENTICULAR DEGENERATION (WILSON'S DISEASE).
    SOURKES TL; MURPHY GF; SANKOFF I; WISEMAN-DISTLER MH; SAINTCYR S
    J Neurochem; 1963 Dec; 10():947-51. PubMed ID: 14090776
    [No Abstract]   [Full Text] [Related]  

  • 10. Indoleamines and affective disorders.
    Coppen A
    J Psychiatr Res; 1972 Sep; 9(3):163-71. PubMed ID: 5083172
    [No Abstract]   [Full Text] [Related]  

  • 11. Excretion patterns of tryptamine, indoleacetic acid, and 5-hydroxyindoleacetic acid, and their correlation with mental changes in schizophrenic patients under medication with alpha-methyldopa.
    Herkert EE; Keup W
    Psychopharmacologia; 1969; 15(1):48-59. PubMed ID: 5367444
    [No Abstract]   [Full Text] [Related]  

  • 12. Biogenic amines derived from tryptophan in systemic and cutaneous scleroderma.
    Stachów A; Jabłońska S; Skiendzielewska A
    Acta Derm Venereol; 1979; 59(1):1-5. PubMed ID: 84460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [STUDIES ON THE RHYTHM OF THE EXCRETION OF 5-HYDROXYINDOLACETIC ACID (5-HIOK) IN THE URINE OF NORMAL SUBJECTS].
    POKORA J; MATUSZEWSKI M; RUPNIEWSKA Z; KOLBER-POSTEPSKA B
    Pol Tyg Lek; 1964 Sep; 19():1444-6. PubMed ID: 14241963
    [No Abstract]   [Full Text] [Related]  

  • 14. VARIATIONS OF URINARY CREATININE AND ITS CORRELATION TO TRYPTAMINE EXCRETION IN SCHIZOPHRENIC PATIENTS.
    BERLET HH; PSCHEIDT GR; SPAIDE JK; HIMWICH HE
    Nature; 1964 Sep; 203():1198-9. PubMed ID: 14213691
    [No Abstract]   [Full Text] [Related]  

  • 15. [Urinary excretion of 5-hydroxyindoleacetic acid (5-HIAA) in 20 atypical cycloid-type psychoses].
    Constantinidis J; Dejaiffe G; Tissot R
    Psychopharmacologia; 1965 Mar; 7(4):266-71. PubMed ID: 5831875
    [No Abstract]   [Full Text] [Related]  

  • 16. [Metabolism of indole substances in schizophrenia with reference to 5-hydroxyindoleacetic acid].
    BUSCAINO GA; STEFANACHI L
    Rass Studi Psichiatr; 1957; 46(6):885-93. PubMed ID: 13527749
    [No Abstract]   [Full Text] [Related]  

  • 17. [INFLUENCE OF THYROID ACTIVITY ON THE URINARY ELIMINATION OF 5-HYDROXYINDOLYLACETIC ACID IN THE RAT].
    GIORGINO R; DADDABBO A
    Folia Endocrinol; 1963 Dec; 16():699-708. PubMed ID: 14152435
    [No Abstract]   [Full Text] [Related]  

  • 18. [STUDIES ON URINARY EXCRETION OF 5-HYDROXYINDOLEACETIC ACID].
    LEE SJ
    Taehan Naekwa Hakhoe Chapchi; 1963 Oct; 6():581-99. PubMed ID: 14121348
    [No Abstract]   [Full Text] [Related]  

  • 19. Excretion of 5-hydroxyindolyl acetic acid (5HIAA) in migraine.
    Curzon G; Theaker P; Phillips B
    J Neurol Neurosurg Psychiatry; 1966 Feb; 29(1):85-90. PubMed ID: 5910583
    [No Abstract]   [Full Text] [Related]  

  • 20. Schizophrenic behavior and urinary tryptophan metabolites associated with cysteine given with and without a monoamine oxidase inhibitor (tranylcypromine).
    Spaide J; Tanimukai H; Ginther R; Bueno J; Himwich HE
    Life Sci; 1967 Mar; 6(5):551-60. PubMed ID: 4226702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.